Biomarkers in chronic obstructive pulmonary disease: confusing or useful?

Por Stockley, Robert A
Publicado em 2014

The multiple facets of alpha-1-antitrypsin

Por Stockley, Robert A.
Publicado no Ann Transl Med (2015)

Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD

Por Vijayasaratha, Kesavaperumal, Stockley, Robert A
Publicado em 2012

Wnt signalling in lung development and diseases

Por Pongracz, Judit E, Stockley, Robert A
Publicado em 2006

Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity – a common inflammatory phenotype?

Por Sevenoaks, Martin J, Stockley, Robert A
Publicado em 2006

The genetics of chronic obstructive pulmonary disease

Por Wood, Alice M, Stockley, Robert A
Publicado em 2006

The many uses of bronchoalveolar lavage

Por Morrison, Heather M, Stockley, Robert A
Publicado em 1988

Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities

Por Sinden, Nicola J., Stockley, Robert A.
Publicado em 2010

Polyclonal free light chains: a biomarker of inflammatory disease or treatment target?

Por Brebner, Judith A., Stockley, Robert A.
Publicado em 2013

The link between chronic periodontitis and COPD: a common role for the neutrophil?

Por Usher, Adam KH, Stockley, Robert A
Publicado no BMC Med (2013)

Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach

Por Stockley, Robert A, Miravitlles, Marc, Vogelmeier, Claus
Publicado em 2013

The rs361525 polymorphism does not increase production of tumor necrosis factor alpha by monocytes from alpha-1 antitrypsin deficient subjects with chronic obstructive pulmonary di...

Por Gane, Jennie M., Stockley, Robert A., Sapey, Elizabeth
Publicado no J Negat Results Biomed (2015)

TNF-α Autocrine Feedback Loops in Human Monocytes: The Pro- and Anti-Inflammatory Roles of the TNF-α Receptors Support the Concept of Selective TNFR1 Blockade In Vivo

Por Gane, Jennie M., Stockley, Robert A., Sapey, Elizabeth
Publicado no J Immunol Res (2016)

Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis

Por Whitehead Philip J, Stockley Robert A, Williams Michael K
Publicado em 2006-12-01

Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis

Por Stockley, Robert A, Whitehead, Philip J, Williams, Michael K
Publicado em 2006

Chronic obstructive pulmonary disease: towards pharmacogenetics

Por Wood, Alice M, Tan, See Ling, Stockley, Robert A
Publicado em 2009

Free light chains: potential biomarker and predictor of mortality in alpha-1-antitrypsin deficiency and usual COPD

Por Hampson, Judith A., Stockley, Robert A., Turner, Alice M.
Publicado no Respir Res (2016)

Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex

Por Sullivan, Anita L, Dafforn, Timothy, Hiemstra, Pieter S, Stockley, Robert A
Publicado em 2008

Patterns and characterization of COPD exacerbations using real-time data collection

Por Ejiofor, Stanley I, Stolk, Jan, Fernandez, Pablo, Stockley, Robert A
Publicado no Int J Chron Obstruct Pulmon Dis (2017)

Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?

Por Stockley, Robert A, Edgar, Ross G, Pillai, Anilkumar, Turner, Alice M
Publicado no Int J Chron Obstruct Pulmon Dis (2016)